Score Overview
See the full market ranking β
Entera Bio Ltd fundamental performance
Between 2020 and 2025, revenue declined from $ 365K to $ 42K and net income went from -$ 9M to -$ 11M. Revenue increased in 1 of those 5 years; net income in 2.
Entera Bio Ltd currently holds a 5-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.80 | β |
1 Year2025-08-12 | $ 1.89 | 48.15% |
5 Years2021-08-12 | $ 5.53 | -49.37% |
All Time2018-06-28 | $ 6.28 | -55.41% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-06-28 |
|---|---|---|---|---|
| Price | $ 2.80 | $ 1.89 | $ 5.53 | $ 6.28 |
| Return | β | 48.15% | -49.37% | -55.41% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 5M | $ 4M |
| 2025 | $ 42K | -$ 11M | $ 7M |
| 2024 | $ 181K | -$ 9M | $ 8M |
| 2023 | $ 14K | -$ 8M | $ 11M |
| 2022 | $ 134K | -$ 13M | $ 12M |
| 2021 | $ 571K | -$ 12M | $ 24M |
| 2020 | $ 365K | -$ 9M | $ 8M |
| 2019 | $ 236K | -$ 10M | $ 15M |
| IPO2018 | $ 500K | -$ 10M | $ 11M |
Explore beyond ENTX
You're looking at Entera Bio Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score β 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
